These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16649520)

  • 1. [Papillary and cavitary monohydrate calcium oxalate lithiasis: comparative study of etiological factors].
    Pieras Ayala E; Grases Freixedas F; Costa Bauzá A; Ramis Barceló M; Pizá Reus P; Ozonas Moragues M
    Arch Esp Urol; 2006 Mar; 59(2):147-54. PubMed ID: 16649520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors.
    Pieras E; Costa-Bauzá A; Ramis M; Grases F
    ScientificWorldJournal; 2006 Apr; 6():2411-9. PubMed ID: 17619710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [May renal lithiasis be really prevented? New trends and therapeutic tools.].
    Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 2017 Jan; 70(1):91-102. PubMed ID: 28221144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the origin of calcium oxalate monohydrate papillary renal stones.
    Grases F; Costa-Bauzá A; Bonarriba CR; Pieras EC; Fernández RA; Rodríguez A
    Urolithiasis; 2015 Jan; 43 Suppl 1():33-9. PubMed ID: 25086903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study.
    Grases F; Costa-Bauzá A; Prieto RM; Conte A; Servera A
    BMC Urol; 2013 Mar; 13():14. PubMed ID: 23497010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pH and renal lithiasis.
    Grases F; Costa-Bauzá A; Gomila I; Ramis M; García-Raja A; Prieto RM
    Urol Res; 2012 Feb; 40(1):41-6. PubMed ID: 21594588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal lithiasis and nutrition.
    Grases F; Costa-Bauza A; Prieto RM
    Nutr J; 2006 Sep; 5():23. PubMed ID: 16956397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin and types of calcium oxalate monohydrate papillary renal calculi.
    Grases F; Costa-Bauzá A; Gomila I; Conte A
    Urology; 2010 Dec; 76(6):1339-45. PubMed ID: 20466410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on structure of calcium oxalate monohydrate renal papillary calculi. Mechanism of formation.
    Grases F; Costa-Bauzá A; Conte A
    Scanning Microsc; 1993 Sep; 7(3):1067-73; discussion 1073-4. PubMed ID: 8146607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the organic matter in calcium oxalate lithiasis.
    Grases F; Isern B; Perello J; Costa-Bauza A
    Front Biosci; 2005 May; 10():1534-8. PubMed ID: 15769643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y
    Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium oxalate monohydrate renal calculi. Formation and development mechanism.
    Söhnel O; Grases F
    Adv Colloid Interface Sci; 1995 Aug; 59():1-17. PubMed ID: 7576314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxalate: its role in lithogenesis and composition of calcium oxalate lithiasis].
    Fernandez Rodríguez A; Arrabal Martín M; Domínguez Molinero JF; Mijan Ortiz JL; Sánchez Tamayo J; Zuluaga Gómez A
    Actas Urol Esp; 1995 Sep; 19(8):620-6. PubMed ID: 8669329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopathological crystallization: a general view about the mechanisms of renal stone formation.
    Grases F; Costa-Bauzá A; García-Ferragut L
    Adv Colloid Interface Sci; 1998 Feb; 74():169-94. PubMed ID: 9561720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monohydrate and dihydrate oxalic lithiasis. Calculi, their macroscopic structure (radiographic and therapeutic impact). Calciuria and oxaluria].
    Thomas J; Charransol-Maistre G; Barthelemy C; Thomas E; Taboury JA; Taillandier E; Desgrez P; Legrand JC; Arvis G; Steg A
    Nephrologie; 1984; 5(4):181-3. PubMed ID: 6527721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.